POLUZZI, ELISABETTA
POLUZZI, ELISABETTA
DIMEC - DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Docenti di ruolo di Ia fascia
Assessing the environmental impact of medicines in Italy using data from the Italian Medicines Agency
2025 Giunchi, Valentina; Fusaroli, Michele; Cangini, Agnese; Fortinguerra, Filomena; Zito, Simona; Pierantozzi, Andrea; Lunghi, Carlotta; Poluzzi, Elisabetta; Trotta, Francesco
Attitudes, barriers, and facilitators toward tools supporting appropriate prescribing among healthcare professionals: a cross-sectional study
2025 Donati, M.; Giunchi, V.; Grillini, G.; Domenicali, M.; Lunardelli, M. L.; Pasini, V.; Milandri, S.; Mussoni, M.; Pieraccini, F.; Sangiorgi, E.; Raschi, E.; Colonnello, V.; Lunghi, C.; Poluzzi, E.
Leveraging digital medication adherence technologies to enhance sustainability of European health systems: ENABLE's key recommendations
2025 van Boven, J. F. M.; Dima, A. L.; Wettermark, B.; Potočnjak, I.; Ágh, T.; Aarnio, E.; Achterbosch, M.; Aksoy, N.; Bago, M.; Barnestein-Fonseca, P.; Bitterman, N.; Burnier, M.; Burton, E.; Charitou, T.; Cordina, M.; Dilles, T.; Dovc, K.; Ekenberg, M.; Elseviers, M.; Fonseca, V. R.; de Geest, S.; Ghiciuc, C. M.; Goetzinger, C.; Gottlieb, H.; Granas, A. G.; Gregório, J.; Hafez, G.; Hansen, K.; Haupenthal, F.; Heerdink, R.; Herdeiro, M. T.; Hiligsmann, M.; Hosszú, D.; Jacome, C.; Kamberi, F.; Kamusheva, M.; Karageorgos, A.; Kardas, P.; Khanyk, N.; Lavalle, S.; Fernández, F. L.; Lunghi, C.; Menditto, E.; Mihajlovic, J.; Mucalo, I.; Mucherino, S.; Makovec, U. N.; Oleárová, A.; Hadžiabdić, M. O.; Petrou, C.; Petrovic, A. T.; Petrova, G.; Pinnock, H.; Poluzzi, E.; Qvarnström, M.; Rackow, P.; Ribaut, J.; Roque, F.; Sahm, L. J.; Schneider, M. P.; Smilkov, K.; Smits, D.; Tadic, I.; Trečiokienė, I.; Tsiligianni, I.; Vermeire, K.; Vervloet, M.; Vlček, J.; Vinker, S.; Volmer, D.; Vrijens, B.; Weinman, J.
The interface of depression and diabetes: treatment considerations
2025 Fanelli, G.; Raschi, E.; Hafez, G.; Matura, S.; Schiweck, C.; Poluzzi, E.; Lunghi, C.
Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals
2024 Lunghi C.; Domenicali M.; Vertullo S.; Raschi E.; De Ponti F.; Onder G.; Poluzzi E.
Call to action: Pharmaceutical residues in the environment: threats to ecosystems and human health: Pharmaceutical Residues in the Environment: Threats to Ecosystems and Human Health
2024 Lunghi, C.; Valetto, M. R.; Caracciolo, A. B.; Bramke, I.; Caroli, S.; Bottoni, P.; Castiglioni, S.; Crisafulli, S.; Cuzzolin, L.; Deambrosis, P.; Giunchi, V.; Grisotto, J.; Marcomini, A.; Moretti, U.; Murgia, V.; Pandit, J.; Polesello, S.; Poluzzi, E.; Romizi, R.; Scarpa, N.; Scroccaro, G.; Sorrentino, R.; Sundström, A.; Wilkinson, J.; Paolone, G.
Enhancing Transparency in Defining Studied Drugs: The Open-Source Living DiAna Dictionary for Standardizing Drug Names in the FAERS
2024 Fusaroli M.; Giunchi V.; Battini V.; Puligheddu S.; Khouri C.; Carnovale C.; Raschi E.; Poluzzi E.
Environmental sustainability-an essential component of rational use of medicines
2024 Giunchi, V; Fusaroli, M; Linder, E; Villén, J; Raschi, E; Lunghi, C; Wettermark, B; Poluzzi, E; Nekoro, M
Environmentally sustainable prescribing: recommendations for EU pharmaceutical legislation
2024 Piët, J. D.; Booth, A.; Donker, E. M.; de Ponti, F.; Lunghi, C.; Poluzzi, E.; Janssen, B. J. A.; Tun, S. Y. M.; Bekker, C.; Dima, L.; Costa, J.; Jalving, M.; Oude Munnink, T. H.; van den Bemt, P. M. L. A.; Labriffe, M.; van Emden, T.; van Waardenburg, V.; Likic, R.; Richir, M.; van Agtmael, M. A.; Moermond, C. T. A.; Tichelaar, J.
Ethical Review of In Silico Methodologies
2024 Rousseau, C. F.; Voisin, E. M.; Poluzzi, E.; Serigado, A.; Viceconti, M.; Jori, M. C.
Learning of clinical pharmacology by future prescribers in Bologna: Teachers' and students' reflections on the way forward
2024 Poluzzi E.; Raschi E.; Lunghi C.; Bertuccio A.; Eleftheriou A.; De Ponti F.
Meta-analyzing Results From Disproportionality Analysis of Individual Case Safety Reports A Note of Caution
2024 Fusaroli, M.; Khouri, C.; Poluzzi, E.; De Ponti, F.; Salvo, F.; Raschi, E.
Peer Review in Pharmacovigilance: Lens on Disproportionality Analysis
2024 Raschi, E.; Salvo, F.; Bate, A.; De Ponti, F.; Poluzzi, E.; Tuccori, M.; van Puijenbroek, E.; Joshi, N.; Khouri, C.
The evolving role of disproportionality analysis in pharmacovigilance
2024 Fusaroli, M.; Raschi, E.; Poluzzi, E.; Hauben, M.
The prevalence of polypharmacy in older Europeans: A multi‐national database study of general practitioner prescribing
2024 Bennie, Marion; Santa‐ana‐tellez, Yared; Galistiani, Githa Fungie; Trehony, Julien; Despres, Johanna; Jouaville, Laurence Sophie; Poluzzi, Elisabetta; Morin, Lucas; Schubert, Ingrid; Macbride‐stewart, Seán; Elseviers, Monique; Nasuti, Paola; Taxis, Katja
The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement
2024 Fusaroli, M.; Salvo, F.; Begaud, B.; Alshammari, T. M.; Bate, A.; Battini, V.; Brueckner, A.; Candore, G.; Carnovale, C.; Crisafulli, S.; Cutroneo, P. M.; Dolladille, C.; Drici, M. -D.; Faillie, J. -L.; Goldman, A.; Hauben, M.; Herdeiro, M. T.; Mahaux, O.; Manlik, K.; Montastruc, F.; Noguchi, Y.; Noren, G. N.; Noseda, R.; Onakpoya, I. J.; Pariente, A.; Poluzzi, E.; Salem, M.; Sartori, D.; Trinh, N. T. H.; Tuccori, M.; van Hunsel, F.; van Puijenbroek, E.; Raschi, E.; Khouri, C.
The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration
2024 Fusaroli, M.; Salvo, F.; Begaud, B.; Alshammari, T. M.; Bate, A.; Battini, V.; Brueckner, A.; Candore, G.; Carnovale, C.; Crisafulli, S.; Cutroneo, P. M.; Dolladille, C.; Drici, M. -D.; Faillie, J. -L.; Goldman, A.; Hauben, M.; Herdeiro, M. T.; Mahaux, O.; Manlik, K.; Montastruc, F.; Noguchi, Y.; Noren, G. N.; Noseda, R.; Onakpoya, I. J.; Pariente, A.; Poluzzi, E.; Salem, M.; Sartori, D.; Trinh, N. T. H.; Tuccori, M.; van Hunsel, F.; van Puijenbroek, E.; Raschi, E.; Khouri, C.
Unveiling the Burden of Drug-Induced Impulsivity: A Network Analysis of the FDA Adverse Event Reporting System
2024 Fusaroli, M.; Polizzi, S.; Menestrina, L.; Giunchi, V.; Pellegrini, L.; Raschi, E.; Weintraub, D.; Recanatini, M.; Castellani, G.; De Ponti, F.; Poluzzi, E.
Behavioral excess and disruptive conduct: A historical and taxonomic approach to the origin of the ‘impulse control disorders’ diagnostic construct
2023 Fusaroli M.; Pellegrini L.; Fusaroli R.; Raschi E.; Menchetti M.; Poluzzi E.
Challenges and Opportunities in Accessing and Analysing FAERS Data: A Call Towards a Collaborative Approach
2023 Giunchi, Valentina; Fusaroli, Michele; Hauben, Manfred; Raschi, Emanuel; Poluzzi, Elisabetta
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Assessing the environmental impact of medicines in Italy using data from the Italian Medicines Agency | Giunchi, Valentina; Fusaroli, Michele; Cangini, Agnese; Fortinguerra, Filomena; Zito, Simona; Pie...rantozzi, Andrea; Lunghi, Carlotta; Poluzzi, Elisabetta; Trotta, Francesco | 2025-01-01 | BJCP. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | Brit J Clinical Pharma - 2025 - Giunchi - Assessing the environmental impact of medicines in Italy using data from the.pdf |
| Attitudes, barriers, and facilitators toward tools supporting appropriate prescribing among healthcare professionals: a cross-sectional study | Donati, M.; Giunchi, V.; Grillini, G.; Domenicali, M.; Lunardelli, M. L.; Pasini, V.; Milandri, S....; Mussoni, M.; Pieraccini, F.; Sangiorgi, E.; Raschi, E.; Colonnello, V.; Lunghi, C.; Poluzzi, E. | 2025-01-01 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | Donati etal. EurJCliniPharm 2025.pdf; 228_2025_3852_MOESM1_ESM.docx |
| Leveraging digital medication adherence technologies to enhance sustainability of European health systems: ENABLE's key recommendations | van Boven, J. F. M.; Dima, A. L.; Wettermark, B.; Potočnjak, I.; Ágh, T.; Aarnio, E.; Achterbosch..., M.; Aksoy, N.; Bago, M.; Barnestein-Fonseca, P.; Bitterman, N.; Burnier, M.; Burton, E.; Charitou, T.; Cordina, M.; Dilles, T.; Dovc, K.; Ekenberg, M.; Elseviers, M.; Fonseca, V. R.; de Geest, S.; Ghiciuc, C. M.; Goetzinger, C.; Gottlieb, H.; Granas, A. G.; Gregório, J.; Hafez, G.; Hansen, K.; Haupenthal, F.; Heerdink, R.; Herdeiro, M. T.; Hiligsmann, M.; Hosszú, D.; Jacome, C.; Kamberi, F.; Kamusheva, M.; Karageorgos, A.; Kardas, P.; Khanyk, N.; Lavalle, S.; Fernández, F. L.; Lunghi, C.; Menditto, E.; Mihajlovic, J.; Mucalo, I.; Mucherino, S.; Makovec, U. N.; Oleárová, A.; Hadžiabdić, M. O.; Petrou, C.; Petrovic, A. T.; Petrova, G.; Pinnock, H.; Poluzzi, E.; Qvarnström, M.; Rackow, P.; Ribaut, J.; Roque, F.; Sahm, L. J.; Schneider, M. P.; Smilkov, K.; Smits, D.; Tadic, I.; Trečiokienė, I.; Tsiligianni, I.; Vermeire, K.; Vervloet, M.; Vlček, J.; Vinker, S.; Volmer, D.; Vrijens, B.; Weinman, J. | 2025-01-01 | THE LANCET REGIONAL HEALTH. EUROPE | - | 1.03 Recensione in rivista | van Boven et al. The Lancet Regional Health - Europe 2025.pdf |
| The interface of depression and diabetes: treatment considerations | Fanelli, G.; Raschi, E.; Hafez, G.; Matura, S.; Schiweck, C.; Poluzzi, E.; Lunghi, C. | 2025-01-01 | TRANSLATIONAL PSYCHIATRY | - | 1.01 Articolo in rivista | Fanelli et al. Translational psychiatry 2025.pdf |
| Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals | Lunghi C.; Domenicali M.; Vertullo S.; Raschi E.; De Ponti F.; Onder G.; Poluzzi E. | 2024-01-01 | DRUG SAFETY | - | 1.01 Articolo in rivista | Lunghi et al. Drug Safety 2024.pdf; 40264_2024_1453_MOESM1_ESM.pdf |
| Call to action: Pharmaceutical residues in the environment: threats to ecosystems and human health: Pharmaceutical Residues in the Environment: Threats to Ecosystems and Human Health | Lunghi, C.; Valetto, M. R.; Caracciolo, A. B.; Bramke, I.; Caroli, S.; Bottoni, P.; Castiglioni, ...S.; Crisafulli, S.; Cuzzolin, L.; Deambrosis, P.; Giunchi, V.; Grisotto, J.; Marcomini, A.; Moretti, U.; Murgia, V.; Pandit, J.; Polesello, S.; Poluzzi, E.; Romizi, R.; Scarpa, N.; Scroccaro, G.; Sorrentino, R.; Sundström, A.; Wilkinson, J.; Paolone, G. | 2024-01-01 | DRUG SAFETY | - | 1.04 Replica / breve intervento (e simili) | - |
| Enhancing Transparency in Defining Studied Drugs: The Open-Source Living DiAna Dictionary for Standardizing Drug Names in the FAERS | Fusaroli M.; Giunchi V.; Battini V.; Puligheddu S.; Khouri C.; Carnovale C.; Raschi E.; Poluzzi E. | 2024-01-01 | DRUG SAFETY | - | 1.01 Articolo in rivista | s40264-023-01391-4.pdf; 40264_2023_1391_MOESM1_ESM.docx |
| Environmental sustainability-an essential component of rational use of medicines | Giunchi, V; Fusaroli, M; Linder, E; Villén, J; Raschi, E; Lunghi, C; Wettermark, B; Poluzzi, E; N...ekoro, M | 2024-01-01 | INTERNATIONAL JOURNAL OF PHARMACY PRACTICE | - | 1.01 Articolo in rivista | - |
| Environmentally sustainable prescribing: recommendations for EU pharmaceutical legislation | Piët, J. D.; Booth, A.; Donker, E. M.; de Ponti, F.; Lunghi, C.; Poluzzi, E.; Janssen, B. J. A.; ...Tun, S. Y. M.; Bekker, C.; Dima, L.; Costa, J.; Jalving, M.; Oude Munnink, T. H.; van den Bemt, P. M. L. A.; Labriffe, M.; van Emden, T.; van Waardenburg, V.; Likic, R.; Richir, M.; van Agtmael, M. A.; Moermond, C. T. A.; Tichelaar, J. | 2024-01-01 | THE LANCET. PLANETARY HEALTH | - | 1.04 Replica / breve intervento (e simili) | - |
| Ethical Review of In Silico Methodologies | Rousseau, C. F.; Voisin, E. M.; Poluzzi, E.; Serigado, A.; Viceconti, M.; Jori, M. C. | 2024-01-01 | - | Springer Nature | 2.01 Capitolo / saggio in libro | 978-3-031-48284-7_7.pdf |
| Learning of clinical pharmacology by future prescribers in Bologna: Teachers' and students' reflections on the way forward | Poluzzi E.; Raschi E.; Lunghi C.; Bertuccio A.; Eleftheriou A.; De Ponti F. | 2024-01-01 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| Meta-analyzing Results From Disproportionality Analysis of Individual Case Safety Reports A Note of Caution | Fusaroli, M.; Khouri, C.; Poluzzi, E.; De Ponti, F.; Salvo, F.; Raschi, E. | 2024-01-01 | JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| Peer Review in Pharmacovigilance: Lens on Disproportionality Analysis | Raschi, E.; Salvo, F.; Bate, A.; De Ponti, F.; Poluzzi, E.; Tuccori, M.; van Puijenbroek, E.; Jos...hi, N.; Khouri, C. | 2024-01-01 | DRUG SAFETY | - | 1.04 Replica / breve intervento (e simili) | - |
| The evolving role of disproportionality analysis in pharmacovigilance | Fusaroli, M.; Raschi, E.; Poluzzi, E.; Hauben, M. | 2024-01-01 | EXPERT OPINION ON DRUG SAFETY | - | 1.01 Articolo in rivista | - |
| The prevalence of polypharmacy in older Europeans: A multi‐national database study of general practitioner prescribing | Bennie, Marion; Santa‐ana‐tellez, Yared; Galistiani, Githa Fungie; Trehony, Julien; Despres, Joha...nna; Jouaville, Laurence Sophie; Poluzzi, Elisabetta; Morin, Lucas; Schubert, Ingrid; Macbride‐stewart, Seán; Elseviers, Monique; Nasuti, Paola; Taxis, Katja | 2024-01-01 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | Brit J Clinical Pharma - 2024 - Bennie - The prevalence of polypharmacy in older Europeans A multi‐national database study (2).pdf; file supplementari (4).zip |
| The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement | Fusaroli, M.; Salvo, F.; Begaud, B.; Alshammari, T. M.; Bate, A.; Battini, V.; Brueckner, A.; Can...dore, G.; Carnovale, C.; Crisafulli, S.; Cutroneo, P. M.; Dolladille, C.; Drici, M. -D.; Faillie, J. -L.; Goldman, A.; Hauben, M.; Herdeiro, M. T.; Mahaux, O.; Manlik, K.; Montastruc, F.; Noguchi, Y.; Noren, G. N.; Noseda, R.; Onakpoya, I. J.; Pariente, A.; Poluzzi, E.; Salem, M.; Sartori, D.; Trinh, N. T. H.; Tuccori, M.; van Hunsel, F.; van Puijenbroek, E.; Raschi, E.; Khouri, C. | 2024-01-01 | DRUG SAFETY | - | 1.01 Articolo in rivista | s40264-024-01421-9.pdf; 40264_2024_1421_MOESM1_ESM.pdf |
| The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration | Fusaroli, M.; Salvo, F.; Begaud, B.; Alshammari, T. M.; Bate, A.; Battini, V.; Brueckner, A.; Can...dore, G.; Carnovale, C.; Crisafulli, S.; Cutroneo, P. M.; Dolladille, C.; Drici, M. -D.; Faillie, J. -L.; Goldman, A.; Hauben, M.; Herdeiro, M. T.; Mahaux, O.; Manlik, K.; Montastruc, F.; Noguchi, Y.; Noren, G. N.; Noseda, R.; Onakpoya, I. J.; Pariente, A.; Poluzzi, E.; Salem, M.; Sartori, D.; Trinh, N. T. H.; Tuccori, M.; van Hunsel, F.; van Puijenbroek, E.; Raschi, E.; Khouri, C. | 2024-01-01 | DRUG SAFETY | - | 1.01 Articolo in rivista | s40264-024-01423-7 (1).pdf |
| Unveiling the Burden of Drug-Induced Impulsivity: A Network Analysis of the FDA Adverse Event Reporting System | Fusaroli, M.; Polizzi, S.; Menestrina, L.; Giunchi, V.; Pellegrini, L.; Raschi, E.; Weintraub, D....; Recanatini, M.; Castellani, G.; De Ponti, F.; Poluzzi, E. | 2024-01-01 | DRUG SAFETY | - | 1.01 Articolo in rivista | s40264-024-01471-z.pdf; 40264_2024_1471_MOESM1_ESM.pdf |
| Behavioral excess and disruptive conduct: A historical and taxonomic approach to the origin of the ‘impulse control disorders’ diagnostic construct | Fusaroli M.; Pellegrini L.; Fusaroli R.; Raschi E.; Menchetti M.; Poluzzi E. | 2023-01-01 | ADDICTION | - | 1.01 Articolo in rivista | Behavioral excess and disruptive conduct A historical and taxonomic approach to the origin of the 'impulse control disorders' diagnostic construct.pdf |
| Challenges and Opportunities in Accessing and Analysing FAERS Data: A Call Towards a Collaborative Approach | Giunchi, Valentina; Fusaroli, Michele; Hauben, Manfred; Raschi, Emanuel; Poluzzi, Elisabetta | 2023-01-01 | DRUG SAFETY | - | 1.01 Articolo in rivista | - |